Company / Operating Income per Share
Sunshine Biopharma Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.25
FY2025
5-year range
-$341.51 / -$0.33
FY2021-FY2025
Trend
+99.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2025 after 4 years of decline, reaching $-2.25.
Based on SEC 10-K filings.
-2.25 in FY2025.
Declined from $-1.20 to $-2.25 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 99.3% year-over-year.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.25 | +99.3% |
| FY2024 | -$341.51 | -28467.0% |
| FY2023 | -$1.20 | -27.0% |
| FY2022 | -$0.94 | -182.7% |
| FY2021 | -$0.33 | -1733.3% |
| FY2020 | -$0.02 | +93.3% |
| FY2019 | -$0.27 | -1356.9% |
| FY2018 | -$0.02 | -1345.7% |
| FY2017 | -$0.00 | +67.2% |
| FY2016 | -$0.00 | +83.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026